S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1175 Events
🤖 AI Analyzed
Recent
📄 Page 42 of 98
NORTH EUROPEAN OIL ROYALTY TRUST
8-K January 16, 2026

Key Highlights

  • Experienced internal Trustee, Nancy J. Floyd Prue, appointed as interim Managing...
  • Ms. Prue brings deep industry expertise with over 35 years in financial manageme...
  • Her existing knowledge of the Trust, having served as a Trustee since 2018, mini...
Read Analysis
🤖 AI Generated
FIRST UNITED CORP/MD/
8-K January 16, 2026

Key Highlights

  • Smooth, planned leadership transition ensuring continuity and reduced market unc...
  • Strengthened leadership structure with Ms. Rodeheaver focusing on high-level str...
  • Internal promotion of Jason B. Rush, a 30-year veteran, signals confidence and d...
Read Analysis
🤖 AI Generated
AES CORP
8-K January 16, 2026

Key Highlights

  • AES is making a major strategic shift away from coal towards renewable energy.
  • The company is committed to decarbonization, aligning its portfolio with future ...
  • This move demonstrates AES's willingness to make tough decisions to accelerate i...
Read Analysis
🤖 AI Generated
SPAR Group, Inc.
8-K January 15, 2026

Key Highlights

  • SPAR Group, Inc. received a formal Nasdaq delisting warning.
  • The warning is due to the company's stock price trading below the minimum $1.00 ...
  • SPAR Group has an initial 180-calendar day period, until approximately July 11, ...
Read Analysis
🤖 AI Generated
FRESH DEL MONTE PRODUCE INC
8-K January 15, 2026

Key Highlights

  • Fresh Del Monte Produce Inc. (FDP) is a global leader in fresh fruit and vegetab...
  • FDP is pursuing a major strategic acquisition to expand capabilities and reach m...
  • The acquisition is part of FDP's growth-focused strategy, indicating expansion r...
Read Analysis
🤖 AI Generated
FEMASYS INC
8-K January 15, 2026

Key Highlights

  • FEMASYS has secured a second 180-day extension from Nasdaq to regain compliance ...
  • The new deadline for FEMASYS to achieve compliance is July 13, 2026.
  • The company is exploring operational improvements, financial restructuring, and ...
Read Analysis
🤖 AI Generated
OFFICE PROPERTIES INCOME TRUST
8-K January 15, 2026

Key Highlights

  • OFFICE PROPERTIES INCOME TRUST (OPI) has officially filed for Chapter 11 bankrup...
  • The proposed reorganization plan explicitly states that all existing common shar...
  • Common shareholders are expected to receive no recovery for their investment.
Read Analysis
🤖 AI Generated
GBT Technologies Inc.
8-K January 15, 2026

Key Highlights

  • New Interim CEO, Patrick Bertagna, appointed with a clear mandate for strategic ...
  • Company is pursuing a reverse stock split and uplisting to a major national stoc...
  • Strategic initiatives aim to increase market visibility and liquidity for the co...
Read Analysis
🤖 AI Generated
Beeline Holdings, Inc.
8-K January 15, 2026

Key Highlights

  • Achieved over 100% revenue growth in 2025 and maintains a strong financial posit...
  • Successfully completed a strategic transformation, including a Nasdaq listing an...
  • Pioneering technology with proprietary AI (e.g., 'Bob' for 6x lead conversions, ...
Read Analysis
🤖 AI Generated
Hepion Pharmaceuticals, Inc.
8-K January 15, 2026

Key Highlights

  • Hepion Pharmaceuticals appointed Dr. Kaouthar Lbiati as new CEO to drive strateg...
  • Dr. Lbiati brings over 20 years of experience in drug development, clinical oper...
  • The appointment aims to speed up the development of key drug candidate, Rencofil...
Read Analysis
🤖 AI Generated
Beyond Air, Inc.
8-K January 15, 2026

Key Highlights

  • Beyond Air is sharpening its focus on its core nitric oxide (NO) delivery platfo...
  • The company received $1 million in upfront cash, strengthening its balance sheet...
  • Beyond Air gained a 19.9% equity stake in XTL Biopharmaceuticals, offering conti...
Read Analysis
🤖 AI Generated
Serina Therapeutics, Inc.
8-K January 15, 2026

Key Highlights

  • Opportunity to submit a detailed plan by February 8, 2026, to regain compliance ...
  • Potential for an 18-month 'Cure Period' until July 9, 2027, if the recovery plan...
  • Positive clinical trial results could enhance the company's ability to raise cap...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage